MSK Immuno-Oncology for the Translational Researcher Short Course

UE5 MSK翻译研究人员免疫肿瘤学短期课程：项目摘要/ 摘要 MSK翻译研究人员免疫肿瘤学短期课程(ITRSC)是一种癌症教育 研究经验将使符合条件的初级NCI资助的教职员工了解肿瘤免疫学， 指导下的当前基于免疫治疗的临床实践和前沿转化研究 专业的理工科教师。计划参与者将在纽约参加一个为期3天的现场研讨会，由以下人员领导 集中参与基础和临床免疫肿瘤学研究。ITRSC参与者还将拥有 有机会从世界免疫肿瘤学专家那里寻求更多的指导和指导。 我们预计，对于国际培训和研究中心的一些参与者来说，这一短期课程将是他们第一次接触到实质性的知识 对于免疫肿瘤学；对于其他方面，深入研究并发症、试验设计和标准的临床方面 治疗的效果会让人大开眼界。通过为他们提供集中和强烈的免疫暴露- 肿瘤学，我们将确保他们对临床和科学技能有适当的了解 帮助开发新的研究思路和临床试验，更好地理解免疫学概念。 该计划的一个主要目标是提高初级教员对免疫肿瘤学的认识和兴趣 研究并提供解决最相关的免疫肿瘤学问题的视角和具体工具 在诊所和实验室的交界处。通过战略招聘NCI资助的科学家和医生 以及对精心挑选的导师和研究主题的接触，ITRSC将提供一条通往 发展能够为癌症生物学和治疗学提供信息的癌症生物学家。 ITRSC将加强参与者关于癌症、免疫学及其关键交叉学科的知识 通过追求以下具体目标： 1.开发课程，通过讲座和培训加深对创新免疫肿瘤学的理解 亲身接触实验技术。 2.在临床和翻译免疫方面为NCI受赠者提供额外的指导和指导- 肿瘤学研究，以培养学员对学术免疫的兴趣和参与 肿瘤学研究。 3.评估强化训练机会在塑造免疫肿瘤学研究方面的效果。 通过ITRSC的曝光，我们希望塑造教职员工对免疫学的看法 应用于癌症研究和临床实践，使许多人将在这一领域进行深入研究。

UE5 MSK Immuno-Oncology for the Translational Researcher Short Course: Project Summary / Abstract The MSK Immuno-Oncology for the Translational Researcher Short Course (ITRSC) is a cancer education research experience that will enable eligible junior NCI-funded faculty to learn about tumor immunology, current immunotherapy-based clinical practice and cutting-edge translational research under the mentorship of expert MSK faculty. Program participants will attend a 3-day workshop onsite in New York, led by those centrally involved in basic and clinical immuno-oncology research. ITRSC participants will also have an opportunity to seek additional mentorship and guidance from world experts on immuno-oncology. We anticipate that for some of the ITRSC participants, this short course will be their first substantive exposure to immuno-oncology; for others, the deep dive into clinical aspects of complications, trial design and standards of therapy will be eye-opening. By providing them with a concentrated and intense exposure to immuno- oncology, we will ensure that they will have the proper understanding to apply their clinical and scientific skills to help develop novel research ideas and clinical trials with a better understanding of immunological concepts. A key goal of this program is to increase the junior faculty’s awareness of and interest in immuno-oncology research and give the perspective and concrete tools to tackle the most pertinent immuno-oncology questions at the interface between clinic and lab. Through strategic recruitment of NCI-funded scientists and physicians and exposure to carefully selected mentors and research topics, the ITRSC will provide a path toward development of cancer biologists capable of informing the vanguard of cancer biology and therapeutics. The ITRSC will enhance the participants’ knowledge about cancer, immunology, and their critical intersection by pursuing the following Specific Aims: 1. Develop a course to form a deep understanding of innovative immuno-oncology through lectures and hands on exposure to experimental techniques. 2. Provide NCI grantees additional mentorship and guidance in both clinical and translational immuno- oncology research in order to foster the trainees’ interest and engagement in academic immuno- oncology research. 3. Evaluate the efficacy of intensive training opportunities in shaping immuno-oncology research. Through the exposure that the ITRSC will enable, we expect to shape the faculty’s perception of immunology applied to cancer research and clinical practice such that many will pursue intensive research in this field.